Posted a quick chart via phone earlier but had to take a look on the desktop. A crucial point here at a supply that once took off 4 years ago.. interesting. Target is $35, leave runners once $36 hits. This could have been a bottom for MRNA but after the rebalancing of the NASDAQ this may bottom out at $30.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.